You are here: Industry Insights > Mucormycosis

News List

Deadly 'Black Fungus' Disease Spotted in Americans With COVID-19 Drugs
December 17, 2021
It's a phenomenon first identified in India earlier this year: Patients who have or are recovering from COVID-19 who then contract a sometimes deadly fungal infection known as mucormycosis -- also known as "black fungus."
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice expresspharma
August 09, 2021
Arun Kedia, Managing Director, VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across various medical therapies ranging from HIV to cancer to COVID-19 treatment.
Supplied lipids for about three lakh vials of Amphotericin B formulations: VAV Life Sciences expresspharma
July 01, 2021
VAV Life Sciences has announced that it has largely fulfilled the demand for lipids used in the production of Amphotericin B, the drug used to treat mucormycosis infections (Black Fungus).
Additional 61,120 vials of Liposomal Amphotericin B allocated to states/UTs and central institutions: Gowda expresspharma
June 25, 2021
The minister wrote on Twitter that so far, approximately 7.9 lakh vials have been allocated across the country, maintaining adequate availability to patients of mucormycosis.
The Pressing Need for Early Detection of Mucormycosis during COVID-19 prnasia
June 22, 2021
Mucormycosis or black fungus, a devastating infection that soars in India during COVID-19 has seized global attention. Recently, the country's mucormycosis cases reached over 57,150 and resulted in 54% mortality.
Govt is taking steps to boost availability of Amphotericin B, allots 6.67 lakh vials to states, UTs expresspharma
June 18, 2021
The existing manufacturers have also been called upon to increase the production of Liposomal Amphotericin-B, informed Chemicals and Fertilisers Ministry.
Lab in India's Telangana State Launches Emulsion-Based Drug for Black Fungus 'Epidemic' firstwordpharma
June 01, 2021
Several pharmaceutical companies are working to find alternative drugs to treat COVID-19-associated mucormycosis in India amid concerns there might be a shortage of amphotericin B, reported Sputnik.
Thousands of 'Black Fungus' Cases Reported in COVID-19 Patients in India drugs
May 25, 2021
India is struggling with thousands of cases of deadly fungal infections in COVID-19 patients and those who have recovered from the disease.
Government working to eliminate shortage of Amphotericin-B drug: Mansukh Mandaviya expresspharma
May 24, 2021
He said that existing pharma companies have already started ramping up the production of the drug which is key for treating mucormycosis, also known as Black Fungus.
MSN Laboratories launches Posaconazole to treat mucormycosis expresspharma
May 24, 2021
MSN has launched the product under the brand name PosaOne as 100 mg Delayed Release tablets and 300 mg injections, respectively.

Previous page 1 2 Next page